References
- Derry S, Moore RA, Gaskell H, et al. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;2015(6):Cd007402.
- Barkin RL. Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome. Am J Ther. 2015;22(5):388–407.
- Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;5(5):Cd008609.
- Manoukian MAC, Migdal CW, Tembhekar AR, et al. Topical administration of ibuprofen for injured athletes: considerations, formulations, and comparison to oral delivery. Sports Med Open. 2017;3(1):36.
- Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 2006;1758(12):2080–2095.
- Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006;19(2):106–121.
- Hagen M, Baker M. Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin. 2017;33(9):1623–1634.
- Roberts MS. Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease. Clin Exp Pharmacol Physiol. 1997;24(11):874–879.
- Roberts MS, Cross SE. Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems. Inflammopharmacology. 1999;7(4):339–350.
- Herkenne C, Alberti I, Naik A, et al. In vivo methods for the assessment of topical drug bioavailability. Pharm Res. 2008;25(1):87–103.
- Howick J, Glasziou P, Aronson JK. The evolution of evidence hierarchies: what can Bradford Hill’s ‘guidelines for causation’ contribute? J R Soc Med. 2009;102(5):186–194.
- Rainsford KD, Kean WF, Ehrlich GE. Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin. 2008;24(10):2967–2992.
- Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81s–110s.
- N’Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014;19(12):20780–20807.
- PubChem [Internet]. Ibuprofen. 2021 [cited 2021 Mar 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/3672
- Hadgraft J, Valenta C. pH, pK(a) and dermal delivery. Int J Pharm. 2000;200(2):243–247.
- Watkinson RM, Guy RH, Hadgraft J, et al. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation. Skin Pharmacol Physiol. 2009;22(4):225–230.
- Dominkus M, Nicolakis M, Kotz R, et al. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung. 1996;46(12):1138–1143.
- McCarberg BH, Argoff CE. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010;64(11):1546–1553.
- PubChem [Internet]. Diclofenac. 2020 [cited 2021 Mar 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Diclofenac
- PubChem [Internet]. Diclofenac sodium. 2020 [cited 2021 Mar 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/5018304
- PubChem [Internet]. Diclofenac epolamine. 2020 [cited 2021 Mar 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/114753
- PubChem [Internet]. Diclofenac diethylammonium. 2020 [cited 2021 Mar 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/86754957
- Benaouda F, Brown MB, Shah B, et al. The influence of self-assembling supramolecular structures on the passive membrane transport of ion-paired molecules. Int J Pharm. 2012;439(1–2):334–341.
- Electronic Medicines Compendium [Internet]. Nurofen joint & muscular pain relief 200mg medicated plaster. London (UK): EMC; 2020 [cited 2021 Mar 23]. Available from: https://www.medicines.org.uk/emc/files/pil.9321.pdf
- Predel HG, Connolly MP, Bhatt A, et al. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from a randomized controlled clinical trial. Phys Sportsmed. 2017;45(4):418–425.
- Predel HG, Giannetti B, Connolly MP, et al. Efficacy and tolerability of a new ibuprofen 200mg plaster in patients with acute sports-related traumatic blunt soft tissue injury/contusion. Postgrad Med. 2018;130(1):24–31.
- Lewis F, Connolly MP, Bhatt A. A pharmacokinetic study of an ibuprofen topical patch in healthy male and female adult volunteers. Clin Pharmacol Drug Dev. 2018;7(7):684–691.
- Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Physiol. 2003;16(3):137–142.
- Bolla PK, Clark BA, Juluri A, et al. Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane. Pharmaceutics. 2020;12(2):151.
- European Medicines Agency [Internet]. Draft guideline on quality and equivalence of topical products. Amsterdam (The Netherlands): EMA; 2018 [cited 2021 Mar 23]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-equivalence-topical-products_en.pdf
- Saninforma [Internet]. Dicloreum Unidie 136 mg Medicated Patch. Rome (Italy): Saninforma; 2018 [cited 2021 Mar 23]. Available from: https://www.saninforma.it/farmaci/dolore-e-infiammazione-ferite/dolori-articolari-e-muscolari-gel-schiume-creme-e-cerotti/dicloreum-unidie-136-mg-cerotto-medicato.html
- Electronic Medicines Compendium [Internet]. Ibuleve max strength pain relief 10% gel. London (UK): EMC; 2020 [cited 2021 Mar 23]. Available from: https://www.medicines.org.uk/emc/product/5689/pil
- Electronic Medicines Compendium [Internet]. Voltarol medicated plaster. London (UK): EMC; 2019 [cited 2021 Mar 23]. Available from: https://www.medicines.org.uk/emc/product/6992/pil
- Electronic Medicines Compendium [Internet]. Voltarol joint pain relief 2.32% gel. London (UK): EMC; 2020 [cited 2021 Mar 23]. Available from: https://www.medicines.org.uk/emc/product/9335/pil
- Fini A, Bassini G, Monastero A, et al. Diclofenac salts, VIII. Effect of the counterions on the permeation through porcine membrane from aqueous saturated solutions. Pharmaceutics. 2012;4(3):413–429.
- Pradal J. Comparison of skin permeation and putative anti-inflammatory activity of commercially available topical products containing ibuprofen and diclofenac. J Pain Res. 2020;13:2805–2814.
- Kleinbloesem CH, Spitznagel W, Wilkinson FE, et al. Pharmacokinetics and bioavailability of percutaneous ibuprofen. Arzneimittelforschung. 1995;45(10):1117–1121.
- Clijsen R, Baeyens JP, Barel AO, et al. In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application. Drug Des Devel Ther. 2015;9:835–840.
- Naik A, Pechtold LA, Potts RO, et al. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release. 1995;37(3):299–306.
- Cilurzo F, Musazzi UM, Franzé S, et al. Design of in vitro skin permeation studies according to the EMA guideline on quality of transdermal patches. Eur J Pharm Sci. 2018;125:86–92.
- European Medicines Agency [Internet]. Guidelines on quality of trans dermal patches. Amsterdam (The Netherlands): EMA; 2014 [cited 2021 Mar 23]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-quality-transdermal-patches_en.pdf
- Wanat K. Biological barriers, and the influence of protein binding on the passage of drugs across them. Mol Biol Rep. 2020;47(4):3221–3231.
- Bohnert T, Gan LS. Plasma protein binding: from discovery to development. J Pharm Sci. 2013;102(9):2953–2994.
- Dancik Y, Anissimov YG, Jepps OG, et al. Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application. Br J Clin Pharmacol. 2012;73(4):564–578.
- Brain KR, Green DM, Dykes PJ, et al. The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo. Skin Pharmacol Physiol. 2006;19(1):17–21.
- Medicines and Healthcare products Regulatory Agency [Internet]. Voltarol 12 hour emugel P2.32% gel. London (UK): MHRA; 2019 [cited 2021 Mar 23]. Available from https://mhraproducts4853.blob.core.windows.net/docs/987fe9df7600bd1520be488ac0fe0ba4bf4ebfc1
- Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–1731.
- Mazaleuskaya LL, Theken KN, Gong L, et al. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015;25(2):96–106.